Alpha1-antitrypsin deficiency.

By Peter C. Gøtzsche, H. K. Johansen. New England Journal of Medicine, 2009

624 citations recorded by the source corpus.

Subfields: Nutrition and Dietetics, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/5cab7f428161d5138acdfcf4bdb63d4f058945bc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Nutrition and Dietetics

1. D. Parums

In Pulmonary and Respiratory Medicine

1. D. Parums

Citations in the corpus

• Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases (2010, background): “, 1994), there is currently no evidence that AAT augmentation therapy is effective in the treatment of WG associated with AAT deficiency (Silverman and Sandhaus, 2009).”
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, positive): “Наиболее документированным генетическим фактором риска является тяжелая наследственная недостаточ ность α1 антитрипсина [26], основного ингибитора се риновых протеиназ в системном кровотоке.”